Gomes-Silva D, Srinivasan M, Sharma S, Lee CM, Wagner DL, Davis TH, Rouce RH, Bao G, Brenner MK, Mamonkin M. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 2017;130(3):285–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Katoh M, Katoh M. Precision medicine for human cancers with Notch signaling dysregulation (Review). Int J Mol Med. 2020;45(2):279–97.
CAS
PubMed
Google Scholar
Liu H, Chiang MY, Pear WS. Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia. Int J Hematol. 2011;94(2):118–25.
Article
CAS
PubMed
Google Scholar
Salah A. Significance of NOTCH1 mutations detections in T-acute lymphoblastic leukemia patients. Cancer Biomark Sect A Dis Mark. 2020;27(2):157–62.
Google Scholar
Meurette O, Mehlen P. Notch signaling in the tumor microenvironment. Cancer Cell. 2018;34(4):536–48.
Article
CAS
PubMed
Google Scholar
Chiang MY, Radojcic V, Maillard I. Oncogenic notch signaling in T-cell and B-cell lymphoproliferative disorders. Curr Opin Hematol. 2016;23(4):362–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tan SH, Bertulfo FC, Sanda T. Leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Front Oncol. 2017;7:218.
Article
PubMed
PubMed Central
Google Scholar
Garcia-Peydro M, Fuentes P, Mosquera M, Garcia-Leon MJ, Alcain J, Rodriguez A, et al. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model. J Clin Investig. 2018;128(7):2802–18.
Article
PubMed
PubMed Central
Google Scholar
Kimura S, Seki M, Yoshida K, Shiraishi Y, Akiyama M, Koh K, et al. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia. Cancer Sci. 2019;110(2):784–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guruharsha KG, Kankel MW, Artavanis-Tsakonas S. The Notch signalling system: recent insights into the complexity of a conserved pathway. Nat Rev Genet. 2012;13(9):654–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhong FF, Yang Y, Liu WJ. Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: a review. Bosn J Basic Med Sci. 2020;4687:1–9.
Google Scholar
Hori K, Sen A, Artavanis-Tsakonas S. Notch signaling at a glance. J Cell Sci. 2013;126(Pt 10):2135–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garcia-Leon MJ, Fuentes P, de la Pompa JL, Toribio ML. Dynamic regulation of NOTCH1 activation and Notch ligand expression in human thymus development. Development. 2018;16:dev165597.
Article
CAS
Google Scholar
Kopan R, Ilagan MXG. The canonical notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Adolfo F. Can one target T-cell ALL? Best practice & research. Clin Haematol. 2018;31(4):361–6.
Google Scholar
Tosello V, Ferrando AA. The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. Ther Adv Hematol. 2013;4(3):199–210.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sorrentino C, Cuneo A, Roti G. Therapeutic targeting of notch signaling pathway in hematological malignancies. Mediterr J Hematol Infect Dis. 2019;11(1):e2019037.
Article
PubMed
PubMed Central
Google Scholar
Yang Y, Li XM, Wang T, Guo QQ, Xi T, Zheng LF. Emerging agents that target signaling pathways in cancer stem cells. J Hematol Oncol. 2020;13(1):60.
Article
PubMed
PubMed Central
Google Scholar
Wei P, Walls M, Qiu M, Ding R, Denlinger RH, Wong A, et al. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design. Mol Cancer Ther. 2010;9(6):1618–28.
Article
CAS
PubMed
Google Scholar
Papayannidis C, DeAngelo DJ, Stock W, Huang B, Shaik MN, Cesari R, et al. A phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Blood Cancer J. 2015;5:e350.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gavai AV, Quesnelle C, Norris D, Han WC, Gill P, Shan WF, et al. Discovery of clinical candidate BMS-906024: a potent pan-notch inhibitor for the treatment of leukemia and solid tumors. ACS Med Chem Lett. 2015;6(5):523–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Knoechel B, Bhatt A, Pan L, Pedamallu CS, Severson E, Gutierrez A, et al. Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. Cold Spring Harbor Lab Press. 2015;1(1):a000539.
Google Scholar
Zweidler-McKay P DD, Douer D. The safety and activity of BMS- 906024, a gamma secretase inhibitor (GSI) with anti-notch activity, in patients with relapsed T-cell acute lymphoblastic leukemia (T-ALL): initial results of a phase I trial [abstract]. Blood. 2014;121(21):Abstract 968.
Maria GB. Adjusting the focus on γ-secretase inhibition. Nat Rev Cancer. 2019;19(8):419.
Article
CAS
Google Scholar
Sanchez-Martin M, Ambesi-Impiombato A, Qin Y, Herranz D, Bansal M, Girardi T, et al. Synergistic antileukemic therapies in NOTCH1 -induced T-ALL. Proc Natl Acad Sci USA. 2017;114(8):2006–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lisa MG. Inhibition of γ-secretase activity synergistically enhances tumour necrosis factor-related apoptosis-inducing ligand induced apoptosis in T-cell acute lymphoblastic leukemia cells via upregulation of death receptor 5. Oncol Lett. 2016;12(4):2900–5.
Article
CAS
Google Scholar
Mendes RD, Canté-Barrett K, Pieters R, Meijerink JPP. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia. Haematologica. 2016;101(9):1010–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hounjet J, Habets R, Schaaf MB, Hendrickx TC, Barbeau L, Yahyanejad S, et al. The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition. Oncogene. 2019;38(27):5457–68.
Article
CAS
PubMed
Google Scholar
Tasian SK, Teachey DT, Rheingold SR. Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies. Front Oncol. 2014;4:108.
PubMed
PubMed Central
Google Scholar
Cullion K, Draheim KM, Hermance N, Tammam J, Sharma VM, Ware C, et al. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood. 2009;113(24):6172–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Real PJ, Ferrando AA. NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia. 2009;23(8):1374–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, De SE, et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med. 2009;15(1):50–8.
Article
CAS
PubMed
Google Scholar
Lian HW, Li D, Zhou Y, Landesman-Bollag E, Zhang G, Anderson NM, et al. CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica. 2017;102(1):e17–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Silva A, Jotta PY, Silveira AB, Ribeiro D, Brandalise SR, Yunes JA, et al. Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors. Haematologica. 2010;95(4):674–8.
Article
CAS
PubMed
Google Scholar
Rao SS, O’Neil J, Liberator CD, Hardwick JS, Dai XD, Zhang T, et al. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. Can Res. 2009;69(7):3060–8.
Article
CAS
Google Scholar
Joshi I, Minter LM, Telfer J, Demarest RM, Capobianco AJ, Aster JC, et al. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood. 2009;113(8):1689–98.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yong R. γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. EMBO Mol Med. 2017;9(7):950–66.
Article
CAS
Google Scholar
Palomero T, Dominguez M, Ferrando AA. The role of the PTEN/AKT pathway in NOTCH1-induced leukemia. Cell Cycle. 2008;7(8):965–70.
Article
CAS
PubMed
Google Scholar
Ma S, Xu J, Wang X, Wu QY, Cao J, Li ZY, et al. Effect of ADAM10 Inhibitor GI254023X on proliferation and apoptosis of acute T-lymphoblastic leukemia jurkat cells in vitro and its possible mechanisms. J Exp Hematol. 2015;23(4):950–5.
CAS
Google Scholar
Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S, et al. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. Leukemia. 2014;28(2):278–88.
Article
CAS
PubMed
Google Scholar
Valentina A, Sonia M, Marica P, Alessandra G, Laura P, Agnese AA, et al. Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts. Haematologica. 2020;105(5):1317–28.
Article
CAS
Google Scholar
Ankur S, Rupali AG, Satthenapalli VR, Krishnanand P, Davanam SM, Lakshmi D, et al. A novel monoclonal antibody against notch1 targets leukemia-associated mutant notch1 and depletes therapy resistant cancer stem cells in solid tumors. Sci Rep. 2015;5:11012.
Article
CAS
Google Scholar
Moellering RE, Cornejo M, Davis TN, Del BC, Aster JC, Blacklow SC, et al. Direct inhibition of the NOTCH transcription factor complex. Nature. 2009;462(7270):182–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gachet S, Genescà E, Passaro D, Irigoyen M, Alcalde H, Clémenson C, et al. Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia. Leukemia. 2013;27(12):2289–300.
Article
CAS
PubMed
Google Scholar
Fleur-Lominy SS, Maus M, Vaeth M, Lange I, Zee I, Suh D, et al. STIM1 and STIM2 mediate cancer-induced inflammation in T cell acute lymphoblastic leukemia. Cell Rep. 2018;24(11):3045–60.
Article
PubMed Central
CAS
Google Scholar
Giovanni R, Anne C, Kenneth NR, Michele M, Kostandin P, Angela HS, et al. Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. Cancer Cell. 2013;23(3):390–415.
Article
CAS
Google Scholar
Giovanni R, Jun Q, Samuel K, Marta SM, Amy SC, Anthony CV, et al. Leukemia-specific delivery of mutant NOTCH1 targeted therapy. J Exp Med. 2018;215(1):197–216.
Article
CAS
Google Scholar
De FC, Heidersdorf B, Haun F, Murillo R, Friedrich T, Borner C, et al. The clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with Notch1 signaling. Cell Death Dis. 2016;7:e2070.
Article
CAS
Google Scholar
Sara CL, Sabine S. Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia. Leukemia Lymphoma. 2016;57(5):1219–22.
Article
Google Scholar
Marchesini M, Gherli A, Montanaro A, Patrizi L, Sorrentino C, Pagliaro L, et al. Blockade of oncogenic NOTCH1 with the SERCA inhibitor CAD204520 in T cell acute lymphoblastic leukemia. Cell Chem Biol. 2020;27:1–20.
Article
CAS
Google Scholar
Diana B, Rocco P, Pia FM, Isabella S, Saula C. Notch signaling as a therapeutic target for acute lymphoblastic leukemia. Expert Opin Ther Targets. 2018;22(4):331–42.
Article
CAS
Google Scholar
Hefazi M, Litzow MR. Recent advances in the biology and treatment of T cell acute lymphoblastic leukemia. Curr Hematol Malig Rep. 2018;13(4):265–74.
Article
PubMed
Google Scholar
Koyama D, Kikuchi J, Hiraoka N, Wada T, Kurosawa H, Chiba S, et al. Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28(6):1216–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wai BM, Vervoort SJ, Kong IY, Heinzel S, Ramsbottom KM, Martin BP, et al. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia. Leukemia. 2018;32(1):237–41.
Article
CAS
Google Scholar
Wang Z, Hu Y, Xiao D, Wang J, Liu C, Xu Y, et al. Stabilization of Notch1 by the Hsp90 chaperone is crucial for T-cell leukemogenesis. Clin Cancer Res. 2017;23(14):3834–46.
Article
CAS
PubMed
Google Scholar
Sanda T, Li XY, Gutierrez A, Ahn Y, Neuberg DS, O’Neil J, et al. Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood. 2010;115(9):1735–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang XL, Lou KY, Song XD, Ma HJ, Zhou XY, Xu H, et al. Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells. Toxicol Appl Pharmacol. 2020;396:115001.
Article
CAS
PubMed
Google Scholar
Agabiti SS, Li J, Dong W, Poe MM, Wiemer AJ. Regulation of the Notch-ATM-abl axis by geranylgeranyl diphosphate synthase inhibition. Cell Death Dis. 2019;10(10):733.
Article
PubMed
PubMed Central
CAS
Google Scholar
Leonetti A, Facchinetti F, Minari R, Cortellini A, Rolfo CD, Giovannetti E, et al. Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges. Cell Oncol (Dordrecht). 2019;42(3):261–73.
Article
CAS
Google Scholar
Zhu W, Zhu Y, Xu H, Wang T, Wang J, Meng M, et al. Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1. Biochem Biophys Res Commun. 2020;522(3):684–9.
Article
CAS
PubMed
Google Scholar
Ohtaka M, Itoh M, Tohda S. BMI1 inhibitors down-regulate NOTCH signaling and suppress proliferation of acute leukemia cells. Anticancer Res. 2017;37(11):6047–53.
CAS
PubMed
Google Scholar
Brandstadter JD, Maillard I. Notch signalling in T cell homeostasis and differentiation. Open Biol. 2019;9(11):190187.
Article
CAS
PubMed
PubMed Central
Google Scholar
Medyouf H, Gao X, Armstrong F, Gusscott S, Liu Q, Gedman AL, et al. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. Blood. 2010;115(6):1175–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aifantis I, Vilimas T, Buonamici S. Notches, NFkappaBs and the making of T cell leukemia. Cell Cycle. 2007;6(4):403–6.
Article
CAS
PubMed
Google Scholar
Choi SH, Severson E, Pear WS, Liu XS, Aster JC, Blacklow SC. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia. PLoS ONE. 2017;12(10):e0185762.
Article
PubMed
PubMed Central
CAS
Google Scholar